Press Release: Ventana : Roche gains CE label expansion for PD-L1 testing in lung and bladder cancers in markets where TECENTRIQ is approved

-- PD-L1 is a protein involved in the suppression of the immune system, which can impact the body's ability to fight cancer -- The VENTANA PD-L1 (SP142) Assay(1) to determine PD-L1 expression in certain lung and bladder cancers may help to inform treatment decisions for the Roche...